Literature DB >> 22992456

Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD(+) biosynthesis.

Hao Yin1, Eric van der Veer, Matthew J Frontini, Victoria Thibert, Caroline O'Neil, Alanna Watson, Peter Szasz, Michael W A Chu, J Geoffrey Pickering.   

Abstract

Cell migration is central to tissue repair and regeneration but must proceed with precise directionality to be productive. Directional migration requires external cues but also depends on the extent to which cells can inherently maintain their direction of crawling. We report that the NAD(+) biosynthetic enzyme, nicotinamide phosphoribosyltransferase (Nampt/PBEF/visfatin), mediates directionally persistent migration of vascular smooth muscle cells (SMCs). Time-lapse microscopy of human SMCs subjected to Nampt inhibition revealed chaotic motility whereas SMCs transduced with the Nampt gene displayed highly linear migration paths. Ordered motility conferred by Nampt was associated with downsizing of the lamellipodium, reduced lamellipodium wandering around the cell perimeter, and increased lamellipodial protrusion rates. These protrusive and polarity-stabilizing effects also enabled spreading SMCs to undergo bipolar elongation to an extent not typically observed in vitro. Nampt was found to localize to lamellipodia and fluorescence recovery of Nampt-eGFP after photobleaching revealed microtubule-dependent transport of Nampt to the leading edge. In addition, Nampt was found to associate with, and activate, Cdc42, and Nampt-driven directional persistence and lamellipodium anchoring required Cdc42. We conclude that high-fidelity SMC motility is coordinated by a Nampt-Cdc42 axis that yields protrusive but small and anchored lamellipodia. This novel, NAD(+)-synthesis-dependent control over motility may be crucial for efficient repair and regeneration of the vasculature, and possibly other tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992456     DOI: 10.1242/jcs.110262

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  An NAD(+) biosynthetic pathway enzyme functions cell non-autonomously in C. elegans development.

Authors:  Matt Crook; Melanie R Mcreynolds; Wenqing Wang; Wendy Hanna-Rose
Journal:  Dev Dyn       Date:  2014-05-10       Impact factor: 3.780

2.  Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases.

Authors:  Hao Yin; Matthew J Frontini; John-Michael Arpino; Zengxuan Nong; Caroline O'Neil; Yiwen Xu; Brittany Balint; Aaron D Ward; Subrata Chakrabarti; Christopher G Ellis; Robert Gros; J Geoffrey Pickering
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

3.  Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.

Authors:  Amro Aboukameel; Irfana Muqbil; William Senapedis; Erkan Baloglu; Yosef Landesman; Sharon Shacham; Michael Kauffman; Philip A Philip; Ramzi M Mohammad; Asfar S Azmi
Journal:  Mol Cancer Ther       Date:  2016-11-15       Impact factor: 6.261

4.  Depletion of the central metabolite NAD leads to oncosis-mediated cell death.

Authors:  Christopher Del Nagro; Yang Xiao; Linda Rangell; Mike Reichelt; Thomas O'Brien
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

5.  Intracellular NAD(H) levels control motility and invasion of glioma cells.

Authors:  Remco van Horssen; Marieke Willemse; Anna Haeger; Francesca Attanasio; Tuba Güneri; Albrecht Schwab; Christian M Stock; Roberto Buccione; Jack A M Fransen; Bé Wieringa
Journal:  Cell Mol Life Sci       Date:  2013-01-10       Impact factor: 9.261

6.  A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention.

Authors:  Xue-Bin Wang; Ning-Hua Cui; Xia'nan Liu
Journal:  Cardiovasc Diabetol       Date:  2022-07-04       Impact factor: 8.949

7.  NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages.

Authors:  Gerda Venter; Frank T J J Oerlemans; Marieke Willemse; Mietske Wijers; Jack A M Fransen; Bé Wieringa
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 8.  Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

Authors:  Noemi Rotllan; Mercedes Camacho; Mireia Tondo; Elena M G Diarte-Añazco; Marina Canyelles; Karen Alejandra Méndez-Lara; Sonia Benitez; Núria Alonso; Didac Mauricio; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.